review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Jonny Karunia Fajar | Q56854787 |
P2093 | author name string | Teuku Heriansyah | |
Budi Susetio Pikir | |||
Erdo Puncak Sidarta | |||
Putu Nina Berlinda Saka | |||
Rizal Rahmanda Akbar | |||
P2860 | cites work | Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides | Q27674442 |
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses | Q28131633 | ||
Angiotensin-converting enzyme gene polymorphisms and hypertension in occupational noise exposure in Egypt | Q30407861 | ||
The angiotensin-I converting enzyme (ACE) gene I/D polymorphism and ACE levels in Pima Indians | Q33677250 | ||
Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure | Q34020659 | ||
Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training | Q34436197 | ||
From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease | Q34515527 | ||
The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition | Q34584353 | ||
New take on the role of angiotensin II in cardiac hypertrophy and fibrosis | Q34993358 | ||
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney | Q35215135 | ||
Influences of the G2350A polymorphism in the ACE gene on cardiac structure and function of ball game players | Q35753476 | ||
Left ventricular hypertrophy--the problem and possible solutions. | Q36285368 | ||
Association of ACE gene D polymorphism with left ventricular hypertrophy in patients with diastolic heart failure: a case-control study. | Q36602874 | ||
Preventing left ventricular hypertrophy by ACE inhibition in hypertensive patients with type 2 diabetes: a prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT). | Q36807421 | ||
Left ventricular hypertrophy and renin-angiotensin system blockade | Q37482193 | ||
Review: association between angiotensin converting enzyme G2350A polymorphism and hypertension risk: a meta-analysis | Q37773740 | ||
Aldosterone is associated with left ventricular hypertrophy in hemodialysis patients | Q38393182 | ||
Left ventricular hypertrophy in acute stroke patients with known hypertension | Q38672505 | ||
Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension | Q40736402 | ||
Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies | Q41894157 | ||
Hypertension and left ventricular hypertrophy | Q42345612 | ||
Angiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expression | Q44152987 | ||
Selection of the dose of angiotensin converting enzyme inhibitor for patients with diabetic nephropathy depends on the presence or absence of left ventricular hypertrophy | Q44250884 | ||
Association of the angiotensin-converting enzyme (ACE) gene G2350A dimorphism with essential hypertension. | Q44592994 | ||
Association of angiotensin converting enzyme gene polymorphisms with left ventricular hypertrophy | Q46683608 | ||
Association of ACE gene insertion/deletion polymorphism with birth weight, blood pressure levels, and ACE activity in healthy children | Q47306778 | ||
Association of ACE gene I/D polymorphism and ACE levels with hemorrhagic stroke: comparison with ischemic stroke | Q48664098 | ||
Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension. | Q51027011 | ||
Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. | Q51037264 | ||
Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. | Q52375631 | ||
Angiotensin-converting enzyme I/D gene polymorphisms and effects of left ventricular hypertrophy in Turkish myocardial infarction patients. | Q54694289 | ||
Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysis | Q57085749 | ||
Angiotensin-converting enzyme and angiotensinogen genes in patterns of left ventricular hypertrophy and in diastolic dysfunction | Q70952649 | ||
DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy | Q72893483 | ||
Hypertensive left ventricular remodeling and ACE-gene polymorphism | Q73120017 | ||
The ACE/DD genotype is associated with the extent of exercise-induced left ventricular growth in endurance athletes | Q73782492 | ||
Usefulness of the I/D angiotensin-converting enzyme genotype for detecting the risk of left ventricular hypertrophy in pharmacologically treated hypertensive men | Q73816323 | ||
Angiotensin-converting enzyme gene polymorphism and geometric patterns of hypertensive left ventricular hypertrophy | Q73975709 | ||
Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approach: focus on treatment by antihypertensive agents | Q77613652 | ||
Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin | Q77643445 | ||
Relation of left ventricular hypertrophy to cardiovascular complications in diabetic hypertensives | Q77756000 | ||
Angiotensin-converting enzyme gene 2350 G/A polymorphism is associated with left ventricular hypertrophy but not essential hypertension | Q80219768 | ||
Ankle-brachial index and ventricular hypertrophy in arterial hypertension | Q83419466 | ||
ACE serum level and I/D gene polymorphism in children with obstructive uropathies and other congenital anomalies of the kidney and urinary tract | Q89248779 | ||
The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: A meta-analysis | Q90812976 | ||
Role of angiotensin-converting enzyme insertion/deletion polymorphism in sudden cardiac arrest | Q91645401 | ||
P433 | issue | 3 | |
P921 | main subject | left ventricular hypertrophy | Q1628627 |
P304 | page(s) | 199-206 | |
P577 | publication date | 2019-05-01 | |
P1433 | published in | Indian heart journal : official publication of the Cardiological Society of India | Q26842841 |
P1476 | title | The Gene Polymorphism of Angiotensin-Converting Enzyme Intron Deletion and Angiotensin-Converting Enzyme G2350A in Patients With Left Ventricular Hypertrophy: A Meta-analysis | |
P478 | volume | 71 |
Search more.